Cargando…
Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method
The durability of bioprosthetic heart valves is always compromised by the inherent antigenicity of biomaterials. Decellularization has been a promising approach to reducing the immunogenicity of biological valves. However, current methods are insufficient in eliminating all immunogenicity from the b...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083275/ https://www.ncbi.nlm.nih.gov/pubmed/37051276 http://dx.doi.org/10.3389/fbioe.2023.1141247 |
_version_ | 1785021472240041984 |
---|---|
author | Song, Mingzhe Yi, Liang Tang, Zhenjie Xie, Xinlong Liu, Yuhong Qi, XiaoKe Jiang, Zhenlin Chen, ZeGuo Chen, Chunyang Wu, QiYing Wu, ZhongShi |
author_facet | Song, Mingzhe Yi, Liang Tang, Zhenjie Xie, Xinlong Liu, Yuhong Qi, XiaoKe Jiang, Zhenlin Chen, ZeGuo Chen, Chunyang Wu, QiYing Wu, ZhongShi |
author_sort | Song, Mingzhe |
collection | PubMed |
description | The durability of bioprosthetic heart valves is always compromised by the inherent antigenicity of biomaterials. Decellularization has been a promising approach to reducing the immunogenicity of biological valves. However, current methods are insufficient in eliminating all immunogenicity from the biomaterials, necessitating the exploration of novel techniques. In this study, we investigated using a novel detergent, fatty alcohol polyoxyethylene ether sodium sulfate (AES), to remove antigens from bovine pericardium. Our results demonstrated that AES treatment achieved a higher pericardial antigen removal rate than traditional detergent treatments while preserving the mechanical properties and biocompatibility of the biomaterials. Moreover, we observed excellent immune tolerance in the in vivo rat model. Overall, our findings suggest that AES treatment is a promising method for preparing biological valves with ideal clinical application prospects. |
format | Online Article Text |
id | pubmed-10083275 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100832752023-04-11 Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method Song, Mingzhe Yi, Liang Tang, Zhenjie Xie, Xinlong Liu, Yuhong Qi, XiaoKe Jiang, Zhenlin Chen, ZeGuo Chen, Chunyang Wu, QiYing Wu, ZhongShi Front Bioeng Biotechnol Bioengineering and Biotechnology The durability of bioprosthetic heart valves is always compromised by the inherent antigenicity of biomaterials. Decellularization has been a promising approach to reducing the immunogenicity of biological valves. However, current methods are insufficient in eliminating all immunogenicity from the biomaterials, necessitating the exploration of novel techniques. In this study, we investigated using a novel detergent, fatty alcohol polyoxyethylene ether sodium sulfate (AES), to remove antigens from bovine pericardium. Our results demonstrated that AES treatment achieved a higher pericardial antigen removal rate than traditional detergent treatments while preserving the mechanical properties and biocompatibility of the biomaterials. Moreover, we observed excellent immune tolerance in the in vivo rat model. Overall, our findings suggest that AES treatment is a promising method for preparing biological valves with ideal clinical application prospects. Frontiers Media S.A. 2023-03-27 /pmc/articles/PMC10083275/ /pubmed/37051276 http://dx.doi.org/10.3389/fbioe.2023.1141247 Text en Copyright © 2023 Song, Yi, Tang, Xie, Liu, Qi, Jiang, Chen, Chen, Wu and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Song, Mingzhe Yi, Liang Tang, Zhenjie Xie, Xinlong Liu, Yuhong Qi, XiaoKe Jiang, Zhenlin Chen, ZeGuo Chen, Chunyang Wu, QiYing Wu, ZhongShi Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method |
title | Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method |
title_full | Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method |
title_fullStr | Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method |
title_full_unstemmed | Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method |
title_short | Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method |
title_sort | preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083275/ https://www.ncbi.nlm.nih.gov/pubmed/37051276 http://dx.doi.org/10.3389/fbioe.2023.1141247 |
work_keys_str_mv | AT songmingzhe preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT yiliang preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT tangzhenjie preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT xiexinlong preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT liuyuhong preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT qixiaoke preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT jiangzhenlin preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT chenzeguo preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT chenchunyang preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT wuqiying preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod AT wuzhongshi preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod |